Company

Intervenn

Rocket Ship Rating

Rocket Ship Rating: 96 out of 100

A NEW FRONTIER IN PRECISION MEDICINE

Also known as InterVenn Biosciences, Venn Biosciences Corporation

Biotech & therapeutics
AI native

Customers: research partners
Legal name: Venn Biosciences Corporation

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

InterVenn Biosciences is a life sciences company unlocking the value of glycoproteomics for the development of transformational healthcare solutions.

Funding snapshot

Total raised: $215MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Round, $173M2021-08-06

Funding rounds

Round, 2021: $173M2021-08-06, SEC form D sold, 14 investors
Round, 2020: $33.7M2020-07-13, SEC form D sold, 15 investors
Round, 2018: $7.5M2018-10-03, SEC form D sold, 10 investors

Products

Other: GlycoKnow Ovarian Cancer Diagnostic Test